Swiss Market Closes Slightly Up
(RTTNews) - Save for a few minutes early on in the session, and a brief while before the closing bell, the Swiss market languished in the red on Monday. Still, the benchmark SMI closed slightly up, with a few frontline stocks finding some good support.
The SMI, which dropped to a low of 11,644.53, closed with a gain of 7.08 points or 0.06% at 11,701.51.
Lonza Group rallied nearly 2.5%. Roche Holding gained about 1.25%. Partners Group, ABB, Sandoz Group, VAT Group and Alcon advanced 0.5 to 0.8%.
Swiss biopharma Basilea Pharmaceutica climbed 4.6% after it entered into an exclusive distribution and license agreement with Innoviva Specialty Therapeutics for the commercialization of Basilea's hospital anti-MRSA antibiotic Zevtera or ceftobiprole in the United States.
Swatch Group closed down 2.73%. Logitech International ended lower by about 2.1%. Nestle and Lindt & Spruengli both lost nearly 1%.
Holcim, Sika, Straumann Holding, Swiss Life Holding, Richemont, Swiss Re, SIG Group, Adecco and UBS Group lost 0.4 to 0.8%.
Data from the Federal Statistical Office said the producer and import prices in Switzerland dropped by 0.6% month-on-month in November, declining for the third straight month, following a 0.3% drop in September.
Producer and import prices decreased by 1.5% year-on-year in November, easing from a 1.8% drop in the previous month.
Eurozone Economic Confidence Weakens In August
Walgreen Co. Now Operating As Private Standalone Company Under Sycamore Partners
U.S. Economy Surges More Than Previously Estimated In Q2
U.S. Weekly Jobless Claims Dip Roughly In Line With Estimates
Switzerland Logs Weaker Growth, Trims 2026 Outlook
U.S. GDP Jumps More Than Previously Estimated In Q2
U.S. Weekly Jobless Claims Edge Down To 229,000
